227 related articles for article (PubMed ID: 31213630)
1. Neutralization of Acidic Intracellular Vesicles by Niclosamide Inhibits Multiple Steps of the Dengue Virus Life Cycle In Vitro.
Jung E; Nam S; Oh H; Jun S; Ro HJ; Kim B; Kim M; Go YY
Sci Rep; 2019 Jun; 9(1):8682. PubMed ID: 31213630
[TBL] [Abstract][Full Text] [Related]
2. The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR.
Kao JC; HuangFu WC; Tsai TT; Ho MR; Jhan MK; Shen TJ; Tseng PC; Wang YT; Lin CF
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006715. PubMed ID: 30125275
[TBL] [Abstract][Full Text] [Related]
3. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
[TBL] [Abstract][Full Text] [Related]
4. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects.
Jurgeit A; McDowell R; Moese S; Meldrum E; Schwendener R; Greber UF
PLoS Pathog; 2012; 8(10):e1002976. PubMed ID: 23133371
[TBL] [Abstract][Full Text] [Related]
5. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
6. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid exhibits antiviral effects against dengue virus infection.
Loe MWC; Hao E; Chen M; Li C; Lee RCH; Zhu IXY; Teo ZY; Chin WX; Hou X; Deng J; Chu JJH
Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
[TBL] [Abstract][Full Text] [Related]
8. In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2.
Alagarasu K; Patil PS; Shil P; Seervi M; Kakade MB; Tillu H; Salunke A
Peptides; 2017 Jun; 92():23-30. PubMed ID: 28400226
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells.
Farias KJ; Machado PR; da Fonseca BA
ScientificWorldJournal; 2013; 2013():282734. PubMed ID: 23431254
[TBL] [Abstract][Full Text] [Related]
10. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
11. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
Franco EJ; Pires de Mello CP; Brown AN
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
[TBL] [Abstract][Full Text] [Related]
13. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of silymarin and baicalein against dengue virus.
Low ZX; OuYong BM; Hassandarvish P; Poh CL; Ramanathan B
Sci Rep; 2021 Oct; 11(1):21221. PubMed ID: 34707245
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
Abdul Ahmad SA; Palanisamy UD; Khoo JJ; Dhanoa A; Syed Hassan S
Virol J; 2019 Feb; 16(1):26. PubMed ID: 30813954
[TBL] [Abstract][Full Text] [Related]
17. Melatonin Inhibits Dengue Virus Infection via the Sirtuin 1-Mediated Interferon Pathway.
Morchang A; Malakar S; Poonudom K; Noisakran S; Yenchitsomanus PT; Limjindaporn T
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920458
[TBL] [Abstract][Full Text] [Related]
18. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
19. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
[TBL] [Abstract][Full Text] [Related]
20. A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant
Panya A; Sawasdee N; Songprakhon P; Tragoolpua Y; Rotarayanont S; Choowongkomon K; Yenchitsomanus PT
Viruses; 2020 Nov; 12(11):. PubMed ID: 33172110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
